1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Orphan Diseases Revenue
1.4 Market by Type
1.4.1 Global Orphan Diseases Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Autoimmune Disorders
1.4.3 Genetic Disorders
1.4.4 Blood Disorders
1.4.5 Cancer
1.4.6 Growth Disorder
1.4.7 Cardiovascular Diseases
1.4.8 Neurological Disorders
1.4.9 Respiratory Disorders
1.4.10 Digestive Disorders
1.4.11 Eye Disorders
1.5 Market by Application
1.5.1 Global Orphan Diseases Market Share by Application: 2020 VS 2026
1.5.2 Hospitals And Clinics
1.5.3 Research Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Orphan Diseases Market Perspective (2015-2026)
2.2 Global Orphan Diseases Growth Trends by Regions
2.2.1 Orphan Diseases Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Orphan Diseases Historic Market Share by Regions (2015-2020)
2.2.3 Orphan Diseases Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Orphan Diseases Market Growth Strategy
2.3.6 Primary Interviews with Key Orphan Diseases Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Orphan Diseases Players by Market Size
3.1.1 Global Top Orphan Diseases Players by Revenue (2015-2020)
3.1.2 Global Orphan Diseases Revenue Market Share by Players (2015-2020)
3.1.3 Global Orphan Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Orphan Diseases Market Concentration Ratio
3.2.1 Global Orphan Diseases Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Orphan Diseases Revenue in 2019
3.3 Orphan Diseases Key Players Head office and Area Served
3.4 Key Players Orphan Diseases Product Solution and Service
3.5 Date of Enter into Orphan Diseases Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Orphan Diseases Historic Market Size by Type (2015-2020)
4.2 Global Orphan Diseases Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Orphan Diseases Market Size by Application (2015-2020)
5.2 Global Orphan Diseases Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Orphan Diseases Market Size (2015-2020)
6.2 Orphan Diseases Key Players in North America (2019-2020)
6.3 North America Orphan Diseases Market Size by Type (2015-2020)
6.4 North America Orphan Diseases Market Size by Application (2015-2020)
7 Europe
7.1 Europe Orphan Diseases Market Size (2015-2020)
7.2 Orphan Diseases Key Players in Europe (2019-2020)
7.3 Europe Orphan Diseases Market Size by Type (2015-2020)
7.4 Europe Orphan Diseases Market Size by Application (2015-2020)
8 China
8.1 China Orphan Diseases Market Size (2015-2020)
8.2 Orphan Diseases Key Players in China (2019-2020)
8.3 China Orphan Diseases Market Size by Type (2015-2020)
8.4 China Orphan Diseases Market Size by Application (2015-2020)
9 Japan
9.1 Japan Orphan Diseases Market Size (2015-2020)
9.2 Orphan Diseases Key Players in Japan (2019-2020)
9.3 Japan Orphan Diseases Market Size by Type (2015-2020)
9.4 Japan Orphan Diseases Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Orphan Diseases Market Size (2015-2020)
10.2 Orphan Diseases Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Orphan Diseases Market Size by Type (2015-2020)
10.4 Southeast Asia Orphan Diseases Market Size by Application (2015-2020)
11 India
11.1 India Orphan Diseases Market Size (2015-2020)
11.2 Orphan Diseases Key Players in India (2019-2020)
11.3 India Orphan Diseases Market Size by Type (2015-2020)
11.4 India Orphan Diseases Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Orphan Diseases Market Size (2015-2020)
12.2 Orphan Diseases Key Players in Central & South America (2019-2020)
12.3 Central & South America Orphan Diseases Market Size by Type (2015-2020)
12.4 Central & South America Orphan Diseases Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Details
13.1.2 Bristol-Myers Squibb Business Overview
13.1.3 Bristol-Myers Squibb Orphan Diseases Introduction
13.1.4 Bristol-Myers Squibb Revenue in Orphan Diseases Business (2015-2020))
13.1.5 Bristol-Myers Squibb Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Orphan Diseases Introduction
13.2.4 Novartis Revenue in Orphan Diseases Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Celgene
13.3.1 Celgene Company Details
13.3.2 Celgene Business Overview
13.3.3 Celgene Orphan Diseases Introduction
13.3.4 Celgene Revenue in Orphan Diseases Business (2015-2020)
13.3.5 Celgene Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview
13.4.3 Roche Orphan Diseases Introduction
13.4.4 Roche Revenue in Orphan Diseases Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview
13.5.3 Pfizer Orphan Diseases Introduction
13.5.4 Pfizer Revenue in Orphan Diseases Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 Alexion
13.6.1 Alexion Company Details
13.6.2 Alexion Business Overview
13.6.3 Alexion Orphan Diseases Introduction
13.6.4 Alexion Revenue in Orphan Diseases Business (2015-2020)
13.6.5 Alexion Recent Development
13.7 Sanofi
13.7.1 Sanofi Company Details
13.7.2 Sanofi Business Overview
13.7.3 Sanofi Orphan Diseases Introduction
13.7.4 Sanofi Revenue in Orphan Diseases Business (2015-2020)
13.7.5 Sanofi Recent Development
13.8 Vertex Pharmaceuticals
13.8.1 Vertex Pharmaceuticals Company Details
13.8.2 Vertex Pharmaceuticals Business Overview
13.8.3 Vertex Pharmaceuticals Orphan Diseases Introduction
13.8.4 Vertex Pharmaceuticals Revenue in Orphan Diseases Business (2015-2020)
13.8.5 Vertex Pharmaceuticals Recent Development
13.9 GlaxoSmithKline
13.9.1 GlaxoSmithKline Company Details
13.9.2 GlaxoSmithKline Business Overview
13.9.3 GlaxoSmithKline Orphan Diseases Introduction
13.9.4 GlaxoSmithKline Revenue in Orphan Diseases Business (2015-2020)
13.9.5 GlaxoSmithKline Recent Development
13.10 Merck
13.10.1 Merck Company Details
13.10.2 Merck Business Overview
13.10.3 Merck Orphan Diseases Introduction
13.10.4 Merck Revenue in Orphan Diseases Business (2015-2020)
13.10.5 Merck Recent Development
13.11 Abbvie
10.11.1 Abbvie Company Details
10.11.2 Abbvie Business Overview
10.11.3 Abbvie Orphan Diseases Introduction
10.11.4 Abbvie Revenue in Orphan Diseases Business (2015-2020)
10.11.5 Abbvie Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
【掲載企業】
Bristol-Myers Squibb、Novartis、Celgene、Roche、Pfizer、Alexion、Sanofi、Vertex Pharmaceuticals、GlaxoSmithKline、Merck、Abbvie
【免責事項】
https://www.globalresearch.jp/disclaimer